Why Tempus AI (TEM) Stock Is Rising
Why Tempus AI (TEM) Stock Is Rising
Tempus AI Inc (NASDAQ:TEM) shares are trading higher by 7.45% to $35.82 during Tuesday's session after the company announced it was granted Advanced Diagnostic Laboratory Test (ADLT) status for its next-generation sequencing assay from the Centers for Medicare & Medicaid Services.
Tempus AI公司（納斯達克：TEM）股價在本週二交易中上漲了7.45%，達到35.82美元，因爲該公司宣佈其下一代測序檢測獲得了醫療保險和醫療服務中心（CMS）的先進診斷實驗室檢測（ADLT）認可。
The company says this makes xT CDx the first FDA-approved sequencing assay to provide tumor mutation profiling through matched normal sequence analysis for patients with solid organ neoplasms.
該公司表示，這使xT CDx成爲首個獲得FDA批准的測序檢測，提供通過匹配正常序列分析的腫瘤突變分析，適用於實體器官腫瘤患者。
The ADLT status additionally confirms that xT CDx meets CMS's criteria for providing unique clinical diagnostic information. The initial reimbursement rate set by CMS is $4,500, applicable from July 1, 2024, to March 31, 2025. After this period, CMS will determine a new Medicare rate based on the median private payer amounts.
ADLT認證還證實，xT CDx滿足CMS提供獨特的臨床診斷信息的標準。CMS設置的初始補償費率爲4500美元，適用於2024年7月1日至2025年3月31日。此後，CMS將根據中位數私人支付者金額確定新的醫療保險費率。
Ezra Cohen, MD, Chief Medical Officer of Oncology at Tempus, highlighted that this designation supports Tempus's mission to enhance patient care through precision medicine and high-quality clinical testing.
Tempus的腫瘤學首席醫學官Ezra Cohen博士強調，此認證支持了Tempus通過精準醫學和高質量臨床檢測提高患者護理的使命。
Read Also: Tesla Deliveries Fall For Second Straight Quarter, But Stock Takes Off As Q2 Numbers Exceed Expectations
閱讀：特斯拉交付量連續第二個季度下降，但第二季度數字超出預期，股票走高
Is TEM A Good Stock To Buy?
TEM是一個好的買入股票嗎？
An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga's quote pages – like Tempus AI's page for example – there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter.
投資者在決定股票是否值得買入時可以做出幾個決策。除了估值指標和價格行動外，您還可以在Benzinga的報價頁面上找到 – 例如Tempus AI的頁面 – 還有像公司是否支付股息或者每個季度購買大量股票這樣的因素。
These are known as capital allocation programs. Tempus AI does not pay a dividend, but obviously has a few ways it can return value to shareholders. Feel free to search Benzinga's dividend calendar for the next company that is due to pay a dividend and determine what kind of yield you can earn for holding a share of the company.
這被稱爲資本配置計劃。Tempus AI不支付股息，但顯然有幾種方法可以向股東回報價值。可以隨時搜索Benzinga的股息日曆，看看下一個即將支付股息的公司，並確定持有該公司的股份可以獲得多少收益。
For example, if you're looking to earn an annualized return of 14.97%, you'll need to buy a share of Global Net Lease by the Jul. 11, 2024. Once done, you can expect to receive a nominal payout of $0.28 on Jul. 16, 2024.
例如，如果你想獲得14.97%的年化回報率，你需要在2024年7月11日之前購買一份Global Net Lease的股份。一旦完成，你可以期望在2024年7月16日獲得0.28美元的名義支付。
Buyback programs are obviously different and highly variable. A company can approve a buyback program and purchase shares as it sees fit over the course of time in which the buyback was authorized. Looking through the latest news on Tempus AI will often yield whether or not the company has approved a buyback program recently. Buyback programs usually serve as a support for share prices, serving as a backstop for demand.
回購計劃顯然不同且高度變化。公司可以批准回購計劃，並在授權的時間內隨時根據自己的情況購買股票。查看關於Tempus AI的最新新聞通常會得出公司最近是否批准了回購計劃的結論。回購計劃通常作爲股價的支撐，爲需求提供了後盾。
According to data from Benzinga Pro, TEM has a 52-week high of $43.88 and a 52-week low of $22.89.
根據Benzinga Pro的數據，TEM的52周最高價爲43.88美元，52周最低價爲22.89美元。
譯文內容由第三人軟體翻譯。